What is 4D Molecular Therapeutics's total revenue?

4D Molecular Therapeutics (FDMT) reported total revenue of $3.05M in Q1 2026.

How has 4D Molecular Therapeutics's total revenue changed year-over-year?

4D Molecular Therapeutics's total revenue increased by 21664.3% year-over-year, from $14K to $3.05M.

What is the long-term trend for 4D Molecular Therapeutics's total revenue?

Over 4 years (2021 to 2025), 4D Molecular Therapeutics's total revenue has grown at a 47.4% compound annual growth rate (CAGR), from $18.04M to $85.21M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

4D Molecular Therapeutics FDMT Total Revenue

Total Revenue at other companies

Eli LillyLLY

$19.8B+55.5%

Regeneron PharmaceuticalsREGN

$3.61B+19.0%

Vertex PharmaceuticalsVRTX

$2.99B+7.8%

EyePoint, Inc. EYPT

$696K-97.2%

AbbVieABBV

$15B+12.4%

RegenxbioRGNX

$6.39M-92.8%

Segments

By geography

See full

JP$2.96M—

US$90K+543%

By product

See full

Collaboration And License Revenue$3.05M+21,664%

Other financials

Income statement

See full

Operating income-$73.6M-37.3%

Net income-$68.8M-43.3%

EPS (diluted)-$1.01-17.4%

Balance sheet

See full

Cash & equivalents$72.5M-45.7%

Total debt$20.5M-13.9%

Total equity$451.8M-3.8%

Total assets$512.9M-0.5%

Cash flow

See full

Operating cash flow-$68.1M-42.6%

CapEx--100%

Free cash flow-$68.1M-40.8%

Valuation

See full

Market cap$602.22M+215%

Enterprise value$550.27M+574%

P/S6.8×-8,306×

Profitability

See full

Operating margin-220.1%-110pp

Net margin-174,314.2%-62,763pp

FCF margin-154,209.2%-53,057pp

Returns & leverage

See full

Return on equity-45.4%+29.8pp

Debt / equity0×0.0×

Current ratio9.3×-3.0×

Where this comes from

Reported directly by 4D Molecular Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about 4D Molecular Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 4D Molecular Therapeutics's total revenue?: 4D Molecular Therapeutics (FDMT) reported total revenue of $3.05M in Q1 2026.
How has 4D Molecular Therapeutics's total revenue changed year-over-year?: 4D Molecular Therapeutics's total revenue increased by 21664.3% year-over-year, from $14K to $3.05M.
What is the long-term trend for 4D Molecular Therapeutics's total revenue?: Over 4 years (2021 to 2025), 4D Molecular Therapeutics's total revenue has grown at a 47.4% compound annual growth rate (CAGR), from $18.04M to $85.21M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.